This site is intended for UK Healthcare Professionals only

UK/FLY/2023/2543 V3 | October 2024

Prescribing information and adverse event reporting statement can be found in the footer

This site is intended for UK Healthcare Professionals only

UK/FLY/2023/2543 V3 | October 2024

Prescribing information and adverse event reporting statement can be found in the footer

Practical and Evidence Based Melatonin Prescribing

This event took place on Friday 4 November 2022
Your certificate will be available in your account once you have watched the on-demand video.

Agenda

Practical and Evidence Based Melatonin Prescribing,Professor Paul Gringras, Professor of Sleep Medicine, Kings College London and Consultant in Paediatric Neurodisability and Sleep Medicine, at the Evelina London Children’s Hospital, Guy’s and St Thomas’ NHS Foundation Trust
Professor Paul Gringras
Professor Paul Gringras
Professor of Sleep Medicine, Kings College London and Consultant in Paediatric Neurodisability and Sleep Medicine, at the Evelina London Children’s Hospital, Guy’s and St Thomas’ NHS Foundation Trust

Professor Paul Gringras specialises in the fields of Paediatric Neurodisability and Paediatric Sleep Medicine. Sleep problems are very common in children and young people with Autism, Attention Deficit Hyperactivity Disorder (ADHD) and many other neurodevelopmental disorders. Improving the sleep, learning, behaviour and quality of life for these children and their families is strong focus of Professor Gringras’ work.

Professor Gringras lectures and runs workshops at national and international conferences. He has written over 70 peer reviewed papers, as well as book and book chapters. He holds research grants in the fields of Neurodisability and Sleep medicine. He lectures internationally and is President elect for the International Paediatric Sleep Association.

His studies include epidemiological work tracking sleep patterns in large numbers of UK children, then studying how sleep differs in those diagnosed with Autism and ADHD. He has conducted two of the world’s largest and longest trials of melatonin to improve sleep in children with Autism.

What will the webinar cover?

Key learning objectives

  • To examine the evidence base for melatonin in paediatric ASD and practical considerations when prescribing pharmacotherapy for paediatric insomnia